Biochips Market - Global Industry Analysis

Biochips Market By Product (DNA Chip, Protein Chip, and Lab-on-a-chip), By Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, and Agriculture), End User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, and Academic & Research Institutes) and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Published Date: 25-Mar-2022 Category: Semiconductor & Electronics Report Format : PDF Pages: 168 Report Code: ZMR-5019 Status : Published

The global market was valued at $12,005 million in 2021 and is projected to reach $25,568 million in 2028. The market is likely to grow with a high CAGR of 11.3% during the forecast period.

Description

Biochips Market Size And Industry Analysis

The global market was valued at $12,005 million in 2021 and is projected to reach $25,568 million in 2028. The market is likely to grow with a high CAGR of 11.3% during the forecast period. The report presents comprehensive projections on the growth factors, opportunities, and restraining factors. It also covers the geographical market along with comprehensive competitive landscape analysis.

Biochip Market: Overview

Biochip is a biosecurity miniaturized medical device which helps in tracking accurate information. Additionally, it is massively used in molecular biology. These chips are capable of undergoing thousands of biological reactions in less time.

COVID-19 Impact:

The outbreak of the Covid-19 pandemic is likely to positively impact the growth of the global biochip market. Its growing applications align with the innovation of the Covid-19 vaccines and drugs, which in turn also contributes to the growth of the market during the pandemic. Its ability to find the gene sequences along with an array of biochemical constituents is likely to play an imperative role in fueling the adoption rate of biochips, particularly among the academic research space. Among the Covid-19 pandemic, the biochip companies are looking forward to capitalizing on the opportunities in the current market landscape. The growing initiatives by the government and big private firms to develop novel solutions to fast track the development of the Covid-19 vaccines and drugs.

Biochip Market: Growth Drivers

Growing usage of biochips in diverse areas will drive the growth of the global market.

Biochip technologies are widely deployed across different areas, including microbiology, DNA analysis, clinical pathology, pharmacology, proctology, and biochemistry, among others. The ongoing research activities will fuel the usage of biochip technologies, particularly in the healthcare industry, which in turn will further expand the usage of biochips in the mainstream market in the forthcoming years. Biochip technology is also being used in sequence engineering, which is likely to augment the growth of the global biochip market and improve the performance & scalability of biochips solutions. Biochip manufacturers are emphasizing innovating distinct aspects of their miniature laboratory that can function properly with living organisms.

Biochips have also emerged as a crucial aspect to revolutionize DNA sequencing technology. Furthermore, it is likely to pave the way for advanced gene sequencing solutions. The combination of gene sequencing technology and biochip will address a number of biological tissues in the rare cell, single-cell, and red molecule analysis. However, biochip technology is growing continuously, and its throughput capacity is likely to expand the scope to diverse applications ranging from population-centric clinical studies to the detection of rare bacteria. Manufacturers are investing heavily in biochips for single-cell analysis. Investments are also likely to contribute towards the improvement of biochips and their versatile functions to enhance performance graphs exponentially.

Global Biochips Market

Biochip Market: Restraints

High cost is a major restraining factor in the global market.

The high cost associated with the instrumentation of biochips is hampering the growth of the global market in emerging markets. However, companies are making efforts to lower the final costs, but still, the cost is quite expensive in developing markets.

Biochip Market: Challenges

Lack of knowledge is a huge challenge in the global market.

Lack of expertise in biochip technology is one of the major challenges in the global biochip market. It is an emerging technology that requires intense training.

Biochip Market: Opportunities

Growing prevalence of chronic disease is likely to create new opportunities in the global market.

The high prevalence of viral infections, immunological and cancer diseases is likely to open new avenues in the global market. The constant spike in the geriatric population will also expand the scope of biochip technology.

Biochip Market: Segmentation

The global biochip market can be segmented into application, end-user, product, and region.

By application, the market can be segmented into agricultural, proteomics, genomics, disease diagnostics, drug discovery & development, and other applications.

By end-user, the market can be segmented into academic & research institutes, hospitals & diagnostic centers, pharmaceuticals, and others.

By product can be segmented into the lab on a chip, protein chip, DNA chip, and others.

Recent Developments

In March 2022, $167 million was raised by Nutcracker Therapeutics in Series C financing to enhance its RNA platform and scale up its mRNA pipeline. Nutcracker is dedicated to developing RNA therapeutics with the use of its biochip-based manufacturing platform. The company believes the funding, directed by ARCH Venture Partners, will allow it to expand its pipeline of mRNA treatment for cancer and improve its platform technology.

Biochip Market: Regional Landscape

Asia Pacific to govern the global market during the forecast period

Asia Pacific accounts for the largest share in the global biochip market due to the fast proliferating pharmaceutical and healthcare sector in the region. Also, the increasing investment in biochip technologies is further likely to complement the growth of the regional market. The ongoing technological advancements, scientific studies, and research & development activities are likely to play a crucial role in the development of the regional market in the forthcoming years.

North America is among the fast-growing regions in the global market due to the growing focus of big organizations on developing cutting-edge biochem technology.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Biochip Market: Competitive Landscape

Some of the significant players in the global biochip market include Thermo Fisher Scientific Inc., Randox Laboratories Ltd., PerkinElmer, Inc., Illumina, Inc., Fluidigm Corporation, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., and bioMerieux S.A.

Global biochip market is segmented as follows:

By Product

  • DNA Chip
  • Protein Chip
  • Lab-on-a-chip

By End User

  • Biotechnology & Pharmaceutical Companies
  • Hospitals & Diagnostics Centers
  • Academic & Research Institutes

By Application

  • Drug Discovery & Development
  • Disease Diagnostics
  • Genomics
  • Proteomics
  • Agriculture

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

 

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Biochips, 2016-2025 (USD Million)
    • 2.2. Biochips: Snapshot
  • Chapter 3. Biochips - Industry Analysis
    • 3.1. Biochips: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Growing prevalence of cancer
      • 3.2.2. Increasing incidence of viral infections and immunological disorders
    • 3.3. Restraints
      • 3.3.1. High cost of biochips
      • 3.3.2. Low awareness in developing regions
    • 3.4. Opportunity
      • 3.4.1. Technological advancements
      • 3.4.2. High investment in research and development
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis By Product
      • 3.6.2. Market attractiveness
      • analysis By Application
      • 3.6.3. Market attractiveness analysis By End User
      • 3.6.4. Market attractiveness analysis by Region
  • Chapter 4. Biochips- Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Biochips: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New product launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Biochips -Product Analysis
    • 5.1. Global Biochips overview: By Product type
      • 5.1.1. Global Biochips share, By Product,2018 and 2025
    • 5.2. Lab-on-a-chip
      • 5.2.1. Global Biochips by Lab-on-a-chip, 2016-2025 (USD Million)
    • 5.3. Protein Chip
      • 5.3.1. Global Biochips by Protein Chip, 2016-2025 (USD Million)
    • 5.4. DNA Chip
      • 5.4.1. Global Biochips by DNA Chip, 2016-2025 (USD Million)
    • 5.5. Resilience Training
      • 5.5.1. Global Biochips by Resilience Training, 2016-2025 (USD Million)
    • 5.6. Others
      • 5.6.1. Global Biochips by others, 2016-2025 (USD Million)
  • Chapter 6. Global Biochips -Application Analysis
    • 6.1. Global Biochips overview: By Application
      • 6.1.1. Global Biochips share, By Application, 2018 and 2025
    • 6.2. Disease Diagnostics
      • 6.2.1. Global Biochips By Disease Diagnostics, 2016-2025 (USD Million)
    • 6.3. Drug Development & Discovery
      • 6.3.1. Global Biochips By Drug Development & Discovery, 2016-2025 (USD Million)
    • 6.4. Proteomics
      • 6.4.1. Global Biochips By Proteomics, 2016-2025 (USD Million)
    • 6.5. Agriculture
      • 6.5.1. Global Biochips By Agriculture, 2016-2025 (USD Million)
    • 6.6. Genomics
      • 6.6.1. Global Biochips By Genomics, 2016-2025 (USD Million)
    • 6.7. Others
      • 6.7.1. Global Biochips by Other Applications, 2016-2025 (USD Million)
  • Chapter 7. Global Biochips -End User Analysis
    • 7.1. Global Biochips overview: By End User
      • 7.1.1. Global Biochips share, By End User, 2018 and 2025
    • 7.2. Hospitals
      • 7.2.1. Global Biochips by Hospitals, 2016-2025 (USD Million)
    • 7.3. Diagnostics Centers
      • 7.3.1. Global Biochips by Diagnostics Centers, 2016-2025 (USD Million)
    • 7.4. Pharmaceutical & Biotechnology Companies
      • 7.4.1. Global Biochips by Pharmaceutical & Biotechnology Companies, 2016-2025 (USD Million)
    • 7.5. Research & Academic Institutes
      • 7.5.1. Global Biochips by Research & Academic Institutes, 2016-2025 (USD Million)
    • 7.6. Others
      • 7.6.1. Global Biochips by Others, 2016-2025 (USD Million)
  • Chapter 8. Global Biochips - Regional Analysis
    • 8.1. Global Biochips overview: by Region
      • 8.1.1. Global Biochips share, by Region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America Biochips, 2016-2025 (USD Million)
      • 8.2.2. North America Biochips revenue, By Product,2016-2025 (USD Million)
      • 8.2.3. North America Biochips revenue, By Application, 2016-2025 (USD Million)
      • 8.2.4. North America Biochips revenue, By End User, 2016-2025 (USD Million)
      • 8.2.5. The U.S.
        • 8.2.5.1. The U.S. Biochips revenue, By Product,2016-2025 (USD Million)
        • 8.2.5.2. The U.S. Biochips revenue, By Application, 2016-2025 (USD Million)
        • 8.2.5.3. The U.S. Biochips revenue, By End User, 2016-2025 (USD Million)
      • 8.2.6. Rest of North America
        • 8.2.6.1. Rest of North America Biochips revenue, By Product,2016-2025 (USD Million)
        • 8.2.6.2. Rest of North America Biochips revenue, By Application, 2016-2025 (USD Million)
        • 8.2.6.3. Rest of North America Biochips revenue, By End User, 2016-2025 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe Biochips, 2016-2025 (USD Million)
      • 8.3.2. Europe Biochips revenue, By Product,2016-2025 (USD Million)
      • 8.3.3. Europe Biochips revenue, By Application, 2016-2025 (USD Million)
      • 8.3.4. Europe Biochips revenue, By End User, 2016-2025 (USD Million)
      • 8.3.5. UK
        • 8.3.5.1. U.K. Biochips revenue, By Product,2016-2025 (USD Million)
        • 8.3.5.2. U.K. Biochips revenue, By Application, 2016-2025 (USD Million)
        • 8.3.5.3. U.K. Biochips revenue, By End User, 2016-2025 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France Biochips revenue, By Product,2016-2025 (USD Million)
        • 8.3.6.2. France Biochips revenue, By Application, 2016-2025 (USD Million)
        • 8.3.6.3. France Biochips revenue, By End User, 2016-2025 (USD Million)
      • 8.3.7. Germany
        • 8.3.7.1. Germany Biochips revenue, By Product,2016-2025 (USD Million)
        • 8.3.7.2. Germany Biochips revenue, By Application, 2016-2025 (USD Million)
        • 8.3.7.3. Germany Biochips revenue, By End User, 2016-2025 (USD Million)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of Europe Biochips revenue, By Product,2016-2025 (USD Million)
        • 8.3.8.2. Rest of Europe Biochips revenue, By Application, 2016-2025 (USD Million)
        • 8.3.8.3. Rest of Europe Biochips revenue, By End User, 2016-2025 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Biochips, 2016-2025 (USD Million)
      • 8.4.2. Asia Pacific Biochips revenue, By Product,2016-2025 (USD Million)
      • 8.4.3. Asia Pacific Biochips revenue, By Application, 2016-2025 (USD Million)
      • 8.4.4. Asia Pacific Biochips revenue, By End User, 2016-2025 (USD Million)
      • 8.4.5. China
        • 8.4.5.1. China Biochips revenue, By Product,2016-2025 (USD Million)
        • 8.4.5.2. China Biochips revenue, By Application, 2016-2025 (USD Million)
        • 8.4.5.3. China Biochips revenue, By End User, 2016-2025 (USD Million)
      • 8.4.6. Japan
        • 8.4.6.1. Japan Biochips revenue, By Product,2016-2025 (USD Million)
        • 8.4.6.2. Japan Biochips revenue, By Application, 2016-2025 (USD Million)
        • 8.4.6.3. Japan Biochips revenue, By End User, 2016-2025 (USD Million)
      • 8.4.7. India
        • 8.4.7.1. India Biochips revenue, By Product,2016-2025 (USD Million)
        • 8.4.7.2. India Biochips revenue, By Application, 2016-2025 (USD Million)
        • 8.4.7.3. India Biochips revenue, By End User, 2016-2025 (USD Million)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific Biochips revenue, By Product,2016-2025 (USD Million)
        • 8.4.8.2. Rest of Asia Pacific Biochips revenue, By Application, 2016-2025 (USD Million)
        • 8.4.8.3. Rest of Asia Pacific Biochips revenue, By End User, 2016-2025 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America Biochips, 2016-2025 (USD Million)
      • 8.5.2. Latin America Biochips revenue, By Product,2016-2025 (USD Million)
      • 8.5.3. Latin America Biochips revenue, By Application, 2016-2025 (USD Million)
      • 8.5.4. Latin America Biochips revenue, By End User, 2016-2025 (USD Million)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil Biochips revenue, By Product,2016-2025 (USD Million)
        • 8.5.5.2. Brazil Biochips revenue, By Application, 2016-2025 (USD Million)
        • 8.5.5.3. Brazil Biochips revenue, By End User, 2016-2025 (USD Million)
      • 8.5.6. Rest of Latin America
        • 8.5.6.1. Rest of Latin America Biochips revenue, By Product,2016-2025 (USD Million)
        • 8.5.6.2. Rest of Latin America Biochips revenue, By Application, 2016-2025 (USD Million)
        • 8.5.6.3. Rest of Latin America Biochips revenue, By End User, 2016-2025 (USD Million)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa Biochips, 2016-2025 (USD Million)
      • 8.6.2. The Middle East and Africa Biochips revenue, By Product,2016-2025 (USD Million)
      • 8.6.3. The Middle East and Africa Biochips revenue, By Application, 2016-2025 (USD Million)
      • 8.6.4. The Middle East and Africa Biochips revenue, By End User, 2016-2025 (USD Million)
  • Chapter 9. Company Profiles
    • 9.1. Bio-Rad Laboratories, Inc.
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. bioMérieux SA
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Illumina, Inc.
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. F. Hoffmann-La Roche AG
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. Thermo Fisher Scientific Inc.
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Development
    • 9.6. Fluidigm Corporation
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Development
    • 9.7. HORIBA, Ltd.
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Development
    • 9.8. PerkinElmer, Inc.
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Development
    • 9.9. PerkinElmer, Inc.
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product Portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Development
    • 9.10. QIAGEN N.V.
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product Portfolio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Development

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Biochips, 2016–2025 (USD Million)
4. Porter’s Five Forces Analysis
5. Global Biochips attractiveness, By Product type
6. Global Biochips attractiveness, By Application
7. Global Biochips attractiveness, By End User
8. Global Biochips market share, By Product, 2018 and 2025
9. Global Biochips by Lab-on-a-chip, 2016–2025 (USD Million)
10.  Global Biochips by Protein Chip,2016–2025 (USD Million)
11.  Global Biochips by DNA Chip,2016–2025 (USD Million)
12.  Global Biochips by Others,2016–2025 (USD Million)
13.  Global Biochips share, By Application, 2018 and 2025
14. Global Biochips By Disease Diagnostics, 2016–2025 (USD Million)
15. Global Biochips By Drug Development & Discovery, 2016–2025 (USD Million)
16. Global Biochips By Proteomics, 2016–2025 (USD Million)
17.  Global Biochips By Agriculture, 2016–2025 (USD Million)
18.  Global Biochips By Genomics, 2016–2025 (USD Million)
19.  Global Biochips By Others, 2016–2025 (USD Million)
20.  Global Biochips share, By End User, 2018 and 2025
21. Global Biochips by Hospitals, 2016–2025 (USD Million)
22. Global Biochips by Diagnostics Centers, 2016–2025 (USD Million)
23.  Global Biochips by Pharmaceutical & Biotechnology Companies, 2016–2025 (USD Million)
24.  Global Biochips by Pharmaceutical & Biotechnology Companies, 2016–2025 (USD Million)
25.  Global Biochips by Others, 2016–2025 (USD Million)
26.  Global Biochips share, by Region, 2018and 2025
27.  North America Biochips, 2016–2025 (USD Million)
28.  Europe Biochips, 2016–2025 (USD Million)
29.  Asia Pacific Biochips, 2016–2025 (USD Million)
30.  Latin America Biochips, 2016–2025 (USD Million)
31.  The Middle East and Africa Biochips, 2016–2025 (USD Million)


Table Of Tables

List of Tables

1. Global Biochips: snapshot
2. Drivers of the Biochips: impact analysis
3. Restraints of the Biochips: impact analysis
4. North America Biochips revenue, By Product,2016–2025 (USD Million)
5. North America Biochips revenue, By Application, 2016–2025 (USD Million)
6. North America Biochips revenue, By End User, 2016–2025 (USD Million)
7. The U.S. Biochips revenue, By Product,2016–2025 (USD Million)
8. The U.S. Biochips revenue, By Application, 2016–2025 (USD Million)
9. The U.S. Biochips revenue, By End User, 2016–2025 (USD Million)
10. Rest of North America Biochips revenue, By Product,2016–2025 (USD Million)
11. Rest of North America Biochips revenue, By Application, 2016–2025 (USD Million)
12. Rest of North America Biochips revenue, By End User, 2016–2025 (USD Million)
13. Europe Biochips revenue, By Product,2016–2025 (USD Million)
14. Europe Biochips revenue, By Application, 2016–2025 (USD Million)
15. Europe Biochips revenue, By End User, 2016–2025 (USD Million)
16. U.K. Biochips revenue, By Product,2016–2025 (USD Million)
17. U.K. Biochips revenue, By Application, 2016–2025 (USD Million)
18. U.K. Biochips revenue, By End User, 2016–2025 (USD Million)
19. France Biochips revenue, By Product,2016–2025 (USD Million)
20. France Biochips revenue, By Application, 2016–2025 (USD Million)
21. France Biochips revenue, By End User, 2016–2025 (USD Million)
22. Germany Biochips revenue, By Product,2016–2025 (USD Million)
23. Germany Biochips revenue, By Application, 2016–2025 (USD Million)
24. Germany Biochips revenue, By End User, 2016–2025 (USD Million)
25. Rest of Europe Biochips revenue, By Product,2016–2025 (USD Million)
26. Rest of Europe Biochips revenue, By Application, 2016–2025 (USD Million)
27. Rest of Europe Biochips revenue, By End User, 2016–2025 (USD Million)
28. Asia Pacific Biochips revenue, By Product,2016–2025 (USD Million)
29. Asia Pacific Biochips revenue, By Application, 2016–2025 (USD Million)
30. Asia Pacific Biochips revenue, By End User, 2016–2025 (USD Million)
31. China Biochips revenue, By Product,2016–2025 (USD Million)
32. China Biochips revenue, By Application, 2016–2025 (USD Million)
33. China Biochips revenue, By End User, 2016–2025 (USD Million)
34. Japan Biochips revenue, By Product,2016–2025 (USD Million)
35. Japan Biochips revenue, By Application, 2016–2025 (USD Million)
36. Japan Biochips revenue, By End User, 2016–2025 (USD Million)
37. India Biochips revenue, By Product,2016–2025 (USD Million)
38. India Biochips revenue, By Application, 2016–2025 (USD Million)
39. India Biochips revenue, By End User, 2016–2025 (USD Million)
40. Rest of Asia Pacific Biochips revenue, By Product,2016–2025 (USD Million)
41. Rest of Asia Pacific Biochips revenue, By Application, 2016–2025 (USD Million)
42. Rest of Asia Pacific Biochips revenue, By End User, 2016–2025 (USD Million)
43. Latin America Biochips revenue, By Product,2016–2025 (USD Million)
44. Latin America Biochips revenue, By Application, 2016–2025 (USD Million)
45. Latin America Biochips revenue, By End User, 2016–2025 (USD Million)
46. Brazil Biochips revenue, By Product,2016–2025 (USD Million)
47. Brazil Biochips revenue, By Application, 2016–2025 (USD Million)
48. Brazil Biochips revenue, By End User, 2016–2025 (USD Million)
49. Rest of Latin America Biochips revenue, By Product,2016–2025 (USD Million)
50. Rest of Latin America Biochips revenue, By Application, 2016–2025 (USD Million)
51. Rest of Latin America Biochips revenue, By End User, 2016–2025 (USD Million)
52. The Middle East and Africa Biochips revenue, By Product,2016–2025 (USD Million)
53. The Middle East and Africa Biochips revenue, By Application, 2016–2025 (USD Million)
54. The Middle East and Africa Biochips revenue, By End User, 2016–2025 (USD Million)
 

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

Biochip technologies are widely deployed across different areas, including microbiology, DNA analysis, clinical pathology, pharmacology, proctology, and biochemistry, among others. The ongoing research activities will fuel the usage of biochip technologies, particularly in the healthcare industry, which in turn will further expand the usage of biochips in the mainstream market in the forthcoming years.

The global market was valued at $12,005 million in 2021 and is projected to reach $25,568 million in 2028. The market is likely to grow with a high CAGR of 11.3% during the forecast period.

Some of the significant players in the global biochip market include Thermo Fisher Scientific Inc., Randox Laboratories Ltd., PerkinElmer, Inc., Illumina, Inc., Fluidigm Corporation, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., and bioMerieux S.A.

Asia Pacific accounts for the largest share in the global biochip market due to the fast proliferating pharmaceutical and healthcare sector in the region. Also, the increasing investment in biochip technologies is further likely to complement the growth of the regional market.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed